申请人:Mirati Therapeutics, Inc.
公开号:US20200331911A1
公开(公告)日:2020-10-22
The present invention relates to compounds that inhibit KRas G12C. In particular, the present invention relates to compounds that irreversibly inhibit the activity of KRas G12C, pharmaceutical compositions comprising the compounds and methods of use therefor.